An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression

NCT00319709 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
288
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi